Business
Press Release Mar 17 2025
Lupin Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Amifampridine Tablets.".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated March 17, 2025, titled \"Lupin Receives Tentative Approval from U.S. FDA for Amifampridine Tablets.\". View Attachment","length":341,"tagName":"div"}]